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Key points
●● Continuous positive airway pressure (CPAP) adherence is low among individuals with obstructive 
sleep apnoea.
●● Type D personality and high scores on the depression and hypochondriasis scales on the 
Minnesota Multiphasic Personality Inventory (MMPI) have been identified as factors contributing 
to non-compliance with CPAP.
●● Further research into personality type may assist in understanding why some people adhere to 
CPAP, while others fail.
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Obstructive sleep apnoea (OSA) is a condition characterised by repetitive, intermittent partial 
or complete collapse/obstruction of the upper airway during sleep. Continuous positive airway 
pressure (CPAP) is highly efficacious in treating OSA but its effectiveness is limited due to 
suboptimal acceptance and adherence rates, with as many as 50% of OSA patients discontinuing 
CPAP treatment within the first year. Until recently, research has focused on examining 
mechanistic and demographic factors that could explain nonadherence (e.g. age, sex, race and 
education level) with limited applicability in a prospective or clinical manner.
More recent research has focused on personality factors or types of patients with OSA who 
comply and do not comply with CPAP adherence in an attempt to enhance the accuracy of 
predicting treatment compliance. Type D personality has been found to be prevalent in one 
third of patients with OSA. The presence of Type D personality increases noncompliance and 
poor treatment outcomes due to negative affectivity, social inhibition, unhealthy lifestyle, and a 
reluctance to consult and/or follow medical advice. Conversely, individuals who are more likely 
to adhere to CPAP treatment tend to have a high internal locus of control and high self-efficacy, 
self-refer for treatment, and have active coping skills. By assessing personality and coping skills, 
the clinician may gain insight into the likelihood of a patient’s adherence to treatment. If the 
patient displays potential risk factors for CPAP noncompliance, the clinician can offer the patient 
education, refer them to a support group, engage in behavioural/motivational therapy and 
undertake regular follow-up visits or phone calls incorporating troubleshooting to increase CPAP 
adherence, especially in individuals with Type D personality.
@sleepresearcher
rlriha@hotmail.comEmily L. Maschauer, Donna M. Fairley, Renata L. Riha
Dept of Sleep Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, 
Edinburgh, UK.
Obstructive sleep apnoea (OSA) is a condition 
characterised by repetitive, intermittent partial or 
complete collapse/obstruction of the upper airway 
during sleep. During wakefulness, dilator muscles 
contract during inspiration to maintain airway 
patency. This prevents collapse as a consequence 
of suction during inspiration. However, during sleep, 
the tone of these muscles falls, causing narrowing 
or total obstruction of the airway.
Continuous positive airway pressure (CPAP) is 
highly efficacious in treating OSA but its effectiveness 
is limited due to suboptimal acceptance and 
adherence rates; 5–89% of patients will reject CPAP 
as a treatment immediately, 25–50% of patients who 
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commence treatment will fail to continue [1–4], 50% 
will discontinue CPAP treatment within 1 year [5] and 
25% terminate CPAP treatment within 3 years [1]. 
This large prevalence of nonadherence decreases its 
effectiveness, and is limited in improving daytime 
sleepiness, mental and physical health, and cognitive 
functioning [1, 6]. These nonadherence numbers are 
similar to other populations with health concerns, 
where roughly 20–40% of individuals with acute 
illness, 30–60% with chronic illness and 50–80% 
of those using preventative care are nonadherent 
to their prescribed medical treatment [5].
Research has focused on finding common 
qualities and/or circumstances that may lead to 
nonadherence, such as age, sex, race, apnoea 
hypopnea index (AHI), body mass index (BMI) and 
education levels, but these have been inconclusive, 
equivocal or confounded by other demographic 
variables [1, 4]. Therefore, more recent research has 
focused on the psychosocial and personality traits 
that may contribute to noncompliance, shifting the 
focus of patient treatment from socioeconomic, 
physical and environmental predictors to that of 
more stable personality factors [1, 2, 5].
Aikens et al. [7] evaluated patients with OSA using 
the Minnesota Multiphasic Personality Inventory 
(MMPI), and discovered that 58% of these patients 
demonstrated at least one MMPI elevation and 38% 
had two or more, with depression, hypochondriasis 
and hysteria being the highest. From this study, 
it was reported that those with core depressive 
symptoms on the MMPI had less severe OSA, and 
those with a diverse set of psychological symptoms 
stronger than depression had a greater AHI and 
lower oxygen saturation [7]. Depressive symptoms 
and anxiety are often seen in patients with OSA, 
which worsens fatigue, but CPAP decreases fatigue 
providing significant improvement in depression 
and anxiety [8]. OSA patient satisfaction with CPAP 
treatment positively correlates with adherence, with 
the greater the day to day improvement noticed the 
greater the likelihood of using CPAP [9].
Methods
Method
We conducted a review of published, peer-reviewed 
articles on personality factors that increase risk of 
nonadherence to CPAP therapy.
Search strategy
The databases used to search the literature for this 
review were MEDLINE (2000–present), EMBASE 
(2000–present), PsycINFO (2000–present), 
SCOPUS (2000–present) and PubMed (2000–
present). These databases allowed for a wide 
range of clinical medical material to be covered 
over a broad base of global journals. Each database 
was searched between August and November 
2016. Recommendations from the Cochrane 
Collaboration for a comprehensive, sensitive and 
wide-variety search were followed to ensure all 
the highest standards in evidence-based research 
were undertaken and all relevant articles for this 
review were identified for review [10]. No conflicts of 
interest were identified. The following search terms 
were used; ([CPAP] OR [continuous positive airway 
pressure]) AND [(OSA) OR (obstructive sleep apnoea 
or obstructive sleep apnea)] AND (personality)] AND 
[(non-compliance or compliance]. The additional 
limit was “to all adult (plus 18 years)” (table 1).
Study selection
All titles and abstracts were assessed and full texts 
of the relevant studies were obtained if they fulfilled 
the required inclusion criteria (see later). Selected 
publications were assessed by two reviewers 
(E.L. Maschauer and D. Fairley) separately to reduce 
selection bias. Once a list of articles was created that 
each reviewer felt met the inclusion criteria, they 
met to compare results and discuss which articles 
would be included in the final review.
Study type
The inclusion criteria were that the studies had to 
investigate personality types, factors or traits in 
individuals with OSA and compliant/noncompliant 
CPAP use. All studies that did not meet the criteria 
or were not peer-reviewed, published articles were 
not included in the review. Duplicate studies and 
those that were not in English were excluded.
Study group
The study group had to have consisted of adults over 
the age of 18 years with OSA on CPAP.
Date of Publication
Studies published between 2000 and 2016 were 
eligible.
This search identified a total of 13 studies to 
be included in the review (table 1). The measures 
used to assess personality factors in these articles 
consisted of the:
●● MMPI, which scores indicators of personality 
characteristics [11, 12];
●● behavioural inhibition system/behavioural 
activation system (BIS/BAS) questionnaires 
exploring appetitive and aversive motives [4];
●● Type D scale (DS14 and DS16) to assess for Type 
D personality [3, 6, 9];
●● Big Five, NEO Five Factor Inventory and Mini-
International Personality Item Pool, which all 
measure the five main domains of personality 
(neuroticism, extraversion, openness, 
agreeableness and conscientiousness) [4, 9];
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●● DOCCO to evaluate stress, personality and 
lifestyle [4];
●● Cognitive Behavioural Assessment, evaluating 
state and trait anxiety, personality characteristics, 
psychophysiological disorders, fears and phobias, 
and depressive behaviours [13];
●● Ways of Coping, measuring different domains or 
aspects of personality, including basic descriptive 
traits, motivation and coping skills [4];
●● Symptom Checklist-90 Revision for psychiatric 
symptoms [14]; and
●● Eysenck Personality Questionnaire to assess 
personality traits measuring psychoticism, 
neuroticism, extraversion and lying [14] (table 2).
Personality traits of 
treatment noncompliers
Several studies have used personality type indicator 
measures (e.g. MMPI and Big Five) to investigate 
individuals with varying degrees of OSA. Type D 
personality appears to be prevalent in 30% of the 
OSA population, in contrast to only 13–24% in the 
general population [3, 5, 6, 9] according to several 
studies conducted in the USA, Sweden, Belgium, 
Canada, Germany and the Netherlands. Type D 
personality is characterised by two traits:
●● negative affectivity, which is the tendency to 
experience negative emotions; and
●● social inhibition, the hindering of emotional and 
behavioural expression for fear of rejection or 
disapproval by others [4–6, 9].
Type D is a predictor of poor health status and 
increased risk of mortality in other medical 
conditions (e.g. chronic pain, mild traumatic brain 
injury and asthma) [9]. Type D has been linked to 
certain negative behaviours such as an unhealthy 
lifestyle, reluctance to consult or follow medical 
advice, and poor treatment outcomes, adversely 
affecting the clinical course of medical conditions 
and treatment compliance [9]. Type D personalities 
are more likely to be anxious, depressed, socially 
inhibited, have a decreased quality of life and 
suffer increased psychological distress [1, 3, 
6, 9, 11]. OSA patients with Type D personality 
have poor medication compliance, and lower 
adherence to CPAP and mandibular advancement 
devices (MADs) than those who are not Type D 
[3, 6]. Roughly 50% of Type D OSA patients use 
their CPAP for <4 h per night, unlike their non-
Type D counterparts who use their CPAP for 6 h 
a night; 45% also discontinue MAD treatment 
[3, 5, 6]. Type D personalities are more likely to 
have medical comorbidities, a decreased personal 
view of their own health, decreased physical 
functioning and poor psychosocial functioning [9]. 
Their subjective perception of the problem does 
not always adequately reflect the actual severity of 
the condition, and they report side-effects of CPAP Ta
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more frequently (e.g. dry throat and mask leaks) [1, 
3, 9]. Type D decreased adherence to CPAP may 
also be caused by decreased perceived effects of 
the treatment and low self-efficacy [3].
When compared to those with snoring, OSA 
patients have significantly higher absolute scores 
on the hypochondriasis, psychopathic deviance 
and depression scales of the MMPI [1, 11]. Scores 
high on the depression and hypochondriasis 
scales also predict low CPAP adherence [16]. 
The hypochondriasis scale measures an over-
concern with one’s state of health [4] and high 
scores indicate extreme attention to physical 
symptoms, chronic fatigue and weakness, and 
noticing vague symptoms, which lead to higher 
rates of noncompliance [11]. High scores on the 
hypochondriasis scale also influence subjective 
daytime sleepiness [12]. High scores on psychopathic 
deviance may show difficulty adhering to rules and 
following the advice of authority figures/medical 
staff, and failing to learn from past mistakes, again 
increasing risk of continual nonadherence [11]. The 
prevalence rate of depression in OSA compared to 
people without OSA is roughly 33%, which may be 
a direct consequence of sleep deprivation or could 
be an indirect consequence of social effects caused 
by the disorder [13], as long-term sleep deprivation 
can adversely affect mood [3]. Individuals with 
OSA tend to have a higher BMI than the normative 
population [15] and obesity is associated with an 
increased risk of depression as well [13].
The personality patterns of OSA patients with 
low CPAP adherence have been found to be a 
somatic–neurotic type, consisting of physical 
symptoms that derive from the psyche more 
than from a physical illness [11]. This increased 
somatic development of symptoms creates a high 
level of psychological distress for the patient, as a 
consequence of OSA, not as a cause of it [11]. Other 
factors that increase low adherence to CPAP are 
OSA patients who exhibit a significantly high level 
of denial of disease severity, hysterical personality 
characteristics, decreased physical activity, feelings 
of guilt, a pessimistic outlook on life and low self-
esteem [11]. Individuals with Type D score high 
on neuroticism, low on extraversion and low on 
conscientiousness when evaluated using the Big 
Five personality model, and score high on the BIS, 
displaying avoidance and aversion to unpleasant 
stimuli [4, 9]. The higher scores on the BIS are 
possibly due to fear and anxiety developing with 
respect to CPAP being an invasive and undeniable 
long-term treatment [4].
Another factor that could give insight into 
whether a patient will have low CPAP adherence is 
knowing who scheduled the patient for treatment. 
If the patient’s partner refers them, rather than the 
patient referring themselves, adherence to CPAP 
decreases [2]. This phenomenon may be due to 
Type D personalities having a high external locus of 
control (e.g. believing their health is determined by 
external forces, not the internal self) or minimising Ta
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their symptoms, thereby not considering treatment 
to be necessary [1–3, 15].
Personality traits of 
treatment compliance
Patients who have a high internal locus of control 
(e.g. believing they have control over their health) 
are more likely to adhere to CPAP treatment [1–3, 
15]. This is due to internalising and following advice 
received from sleep specialists, having the ability 
not to perseverate on treatment side-effects, and 
displaying high self-efficacy [2]. High self-efficacy 
empowers individuals to believe in their own ability 
to deal with obstacles and take control of their own 
health [5], thus increasing treatment compliance. 
This also explains why self-referring patients are 
more likely to adhere to treatment.
Individuals with a high level of conscientiousness 
and openness, active coping skills, and problem 
solving traits are also most likely to adhere to 
treatment [4]. Implementation of coping strategies/
skills in demanding situations can lead to a higher 
overall level of CPAP use per night and continued 
use over time [2].
CPAP adherence is also increased if a patient 
is educated on the negative health outcomes that 
will develop as a result of not using the treatment, 
as well as believing they have a more severe form 
of the disorder [2]. Physiological measures of 
disease severity rarely accurately predict >10% 
of the variance in adherence [1] but the patient’s 
belief that his/her OSA is severe will lead to higher 
treatment compliance.
Those who comply more with CPAP tend to have 
a higher BMI, report less daytime sleepiness, report 
better nocturnal sleep quality, and score lower on 
the depression and hypochondriasis scales on the 
MMPI prior to treatment [16]. These five predictors 
identify ∼80% of individuals who eventually fail to 
comply with CPAP treatment as well as 97% of 
those who comply long-term [16].
Discussion
Despite CPAP being an effective treatment 
for OSA, improving quality of sleep, excessive 
daytime sleepiness (EDS) and road accidents, 
patient adherence to this device is relatively low. 
By better understanding which factors play into 
the prediction of treatment noncompliance, health 
professionals can create preventative plans and 
support systems for patients to increase adherence. 
One way to increase CPAP adherence is for clinicians 
to use a short personality inventory (DS14 is 
recommended [9]) and a coping skills questionnaire 
to evaluate OSA patients. From this information, 
clinicians can determine if the patient has a Type 
D personality and assess active coping skills, 
whilst the patient awaits CPAP titration. Screening 
patients before treatment may allow clinicians 
the opportunity of prescribing a structured, well-
designed intervention that is focused on improving 
the patient’s self-management, coping skills and 
self-efficacy, thus improving adherence and long-
term continuation of CPAP [3, 6].
Assessing for anxiety and depression pre-
treatment has been found to strongly predict CPAP 
adherence and may lead to better subsequent 
CPAP use by educating the patient on how CPAP 
decreases depression and anxiety [1, 4, 5]. The 
goal of the CPAP titration appointment should not 
simply be about treating OSA but should include 
education on OSA and CPAP, enhance patient 
acceptance of the treatment, and provide continual 
support and education, encouraging long-term 
adherence [1].
Intense educational programmes, mask 
fitting and a familiarisation session with CPAP 
prior to CPAP titration also increase adherence 
[2, 3, 5, 17, 18]. Training by a sleep specialist or 
nurse coupled with a video depicting information 
on OSA, symptoms, health consequences and 
Educational questions
1. What are the characteristics of Type D personality?
a) Relaxed, easy going and prone to few health concerns
b) Usually stressed, negative emotions, social inhibition and fear of 
rejection/disapproval of others
c) Highly strung, organised and unwilling to change or adapt to new 
situations
d) A mix between Type A (organised) and Type B (relaxed)
2. What are the characteristics of those who are compliant with continuous 
positive airway pressure (CPAP)?
a) Relaxed, easy going and prone to few health concerns
b) Usually stressed, unable to cope with everyday problems and having an 
overly involved partner
c) Negative emotions, social inhibition and introverted
d) High internal locus of control, high self-efficacy and active coping skills
3. What can specialists/doctors do to increase CPAP adherence?
a) Wait 4 weeks after giving CPAP and check with the patient
b) Use a personality inventory, coping skills questionnaire, educational 
programmes/sessions and giving information booklets
c) Stress the importance of CPAP but if a patient is not going to use the 
machine, there is little that can be done
d) Introduce a CPAP compliance smartphone app into the patient’s care plan
4. How can partners affect CPAP adherence?
a) Supporting/reinforcing the patient’s desire to use CPAP increases 
adherence
b) Partners who complain about the noise the CPAP machine emits 
decrease CPAP adherence
c) Partners who come to the doctor’s appointments with the patient 
increase CPAP asherence
d) Partners who make doctor’s appointments for the patient decrease 
CPAP adherence
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pathophysiology, as well as what a CPAP machine 
is, how to use it and the benefits of CPAP, should 
all take place before the patient goes home with 
the machine. By alerting the patient to the medical 
and daytime consequences (e.g. weight gain and 
EDS) of untreated OSA, highlighting the advantages 
of the treatment (e.g. relationship improvement), 
downplaying the disadvantages, and stressing the 
consequences of nonadherence, adherence to CPAP 
actually increases [6]. Patients should be given a 
take-home booklet with this information to refer 
to as necessary and given ongoing education after 
each clinical visit. There is evidence that providing 
literature that outlines the value and importance of 
regular CPAP use increases nightly use by 2.7 more 
hours a night [1].
If the patient has a Type D personality, early 
intervention within the first few days of commencing 
CPAP therapy using cognitive behavioural therapy 
(CBT), Motivational Enhancement Therapy or 
motivational interviewing intervention provides 
coping skills, improves self-efficacy and provides a 
positive view of the treatment [17, 19, 20]. Type D 
patients do not effectively cope with stressful life 
events; therefore, psychological interventions 
(e.g. CBT) focusing on training and teaching coping 
skills to decrease stress and increase disease 
management skills not only benefit the patient, 
but also increase CPAP use by 2.7–3.2 h a night 
[1, 5, 9]. Social support groups improve adherence 
by increasing positive emotions associated with 
treatment, peer motivation to continue using CPAP 
long-term [1, 4, 5] and provide coping skills/self-
management tools among peers [5].
An important aspect of predicting compliance 
is to evaluate the perception of symptoms and 
improvement of those with Type D since these 
individuals tend to perseverate on the perception 
of symptoms or side-effects [5]. Therefore, another 
critical component to increasing adherence is 
providing nursing support and follow-up phone 
calls, particularly during the first month of CPAP 
use [18, 21]. These troubleshooting telephone 
calls have a positive impact, increasing CPAP use 
by >1.4 h a night [1]. Telemonitoring (e.g. talking 
with the patient via Skype instead of in person) also 
improves CPAP adherence and decreases depressive 
symptoms [22]. This support, coupled with patient 
visits to the sleep centre will provide immediate 
troubleshooting as well as detect early patterns of 
CPAP use, allowing further intervention if necessary 
[1, 5, 18, 21]. It is recommended these follow-up 
phone calls and clinical visits should be within the 
first few days after treatment has commenced, and 
then again after 6 weeks, 3 months, 6 months and 
then yearly [5]. Well-designed patient-educational 
and support programmes coupled with follow-up 
visits and phone calls can lead to superior adherence 
of 84% with ≥4 h a night [5, 23].
Lastly, enlisting the support of a significant 
other is a potential factor that can increase 
CPAP adherence [1, 5], as CPAP use positively 
affects relationship quality. Partners should be 
encouraged to allow the patient to make their 
own appointments, as adherence increases when 
patients feel they have a sense of self-control 
over their disease. While personality type is an 
important factor to consider in the management 
of OSA patients, interventions focusing on lifestyle 
(diet and exercise) could also improve mood, 
wellbeing and, potentially, CPAP compliance [24]. 
A comprehensive strategy should be aimed for in 
all OSA patients.
Most of the studies to date on CPAP adherence 
and personality have used small sample sizes or 
are case studies, and have not investigated Type 
A (organised, anxious) or Type B (relaxed, creative) 
personality types in this population. CPAP treatment 
compliance is imperative to decrease mortality 
rates, decrease economic costs, and increase the 
quality of life of individuals with OSA and their 
families. There is a need for more research in 
understanding and targeting interventions aimed 
at psychosocial predictors of CPAP adherence, and 
developing better, more effective and bespoke 
treatment plans. Since personality traits are not 
stable and can transform over time after use of an 
intervention or positive experiences, more research 
is warranted focusing on cognitive variables 
[2, 5, 11]. For example, there have not been any 
studies investigating the change in MMPI scores 
after CPAP use has been initiated and maintained. 
Further investigation is necessary to understand 
how health professionals can increase CPAP 
adherence and empower patients to deal with their 
own disease.
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